Nanocarrier-Based Approach: Solid Lipid Nanoparticles for the Enhanced Bioavailability of Febuxostat DOI

Shehram Qazafi,

Danish Mazhar,

Dur e Nayab

et al.

BioNanoScience, Journal Year: 2025, Volume and Issue: 15(2)

Published: March 20, 2025

Language: Английский

Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices DOI
Devendra Birla, Nikhil Khandale, Bushra Bashir

et al.

Drug Delivery and Translational Research, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 10, 2024

Language: Английский

Citations

6
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods DOI
Faezeh Fathi, Tatiane de Oliveira Xavier Machado, Helena de Almeida Cerqueira Kodel

et al.

Expert Opinion on Drug Delivery, Journal Year: 2024, Volume and Issue: 21(10), P. 1479 - 1490

Published: Oct. 2, 2024

Nanoparticles (NPs) are widely used in the pharmaceutical field to treat various human disorders. Among these, lipid-based NPs (LNPs), including solid lipid nanoparticles (SLN) and nanostructured carriers (NLC), favored for drug/bioactive delivery due their high stability, biocompatibility, encapsulation efficiency, sustained/controlled release. These properties make them particularly suitable as of compounds derived from plant sources.

Language: Английский

Citations

6
Weaponizing chitosan and its derivatives in the battle against lung cancer DOI
Haitham Amin, Islam M. Ibrahim,

Emad H.M. Hassanein

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 272, P. 132888 - 132888

Published: June 1, 2024

Language: Английский

Citations

5
Transforming cancer treatment: The potential of nanonutraceuticals DOI Creative Commons
Girish Kumar, Tarun Virmani,

Vaishnavi Chhabra

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 667, P. 124919 - 124919

Published: Nov. 7, 2024

Language: Английский

Citations

5
Stimuli-Responsive Nanogel/Microgel Hybrids as Targeted Drug Delivery Systems: A Comprehensive Review DOI

Amrita Ghosh Majumdar,

Biswajit Pany,

Sankha Subhra Parua

et al.

BioNanoScience, Journal Year: 2024, Volume and Issue: 14(3), P. 3496 - 3521

Published: Aug. 13, 2024

Language: Английский

Citations

4
DESIGN AND DEVELOPMENT OF SOLID LIPID NANOPARTICLES CONTAINING ROSUVASTATIN USING CENTRAL COMPOSITE DESIGN DOI Open Access
DISHARI DUTTA,

Pranabesh Chakraborty,

Chowdhury Mobaswar Hossain

et al.

International Journal of Applied Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 82 - 91

Published: Jan. 7, 2025

Objective: Rosuvastatin calcium, a BCS class II drug with low solubility, was optimized using central composite design to improve its bioavailability. Methods: The study utilized Kolliphor RH 40 as an emulsifier and glyceryl monostearate solid lipid in preparing nanoparticle dispersion, optimizing formulations based on mean dissolution time entrapment efficiency. Results: analyzed the efficiency of prepared nanoparticles. range found 7.1+0.5 8.9+0.6 h. highest be 90.28%, standard deviation 0.2. linear model chosen data precision trend, while quadratic selected for time. 3D view graph indicated model/equation followed by formulations. formulation had particle size 16.16+10 nm distribution index 0.729+002, indicating high homogeneity. Transmission electron microscopy images dynamic light scattering were correlation. XRD, DSC used analyze drug's transformation into amorphous form. profile different plotted, Korsmeyer-Peppas model. FTIR showed peaks, no interaction. Conclusion: suggested that bioavailability rosuvastatin calcium can enhanced through preparation nanoparticles smaller sustained release rosuvastatin.

Language: Английский

Citations

0
Recent advances in lipid-based nanocarriers for advanced skin cancer therapy DOI

Mohd Shoab Ali,

Mohammad Ali Abdullah Almoyad, Shadma Wahab

et al.

International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125203 - 125203

Published: Jan. 1, 2025

Language: Английский

Citations

0
Erlotinib encapsulated oral chitosan modified lipid nanoparticles for lung cancer DOI
Najla Altwaijry, Sadaf Jamal Gilani,

Ahlam Sultan

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: 105, P. 106612 - 106612

Published: Jan. 9, 2025

Language: Английский

Citations

0
Encapsulation of synthesized purpurin-18-N-aminoimide methyl ester in lipid nanovesicles for use as agents in photodynamic cancer therapy DOI
Sooho Yeo, Huiqiang Wu,

Young Kyu Song

et al.

Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0
Development of propranolol loaded SLN for transdermal delivery: in-vitro characterization and skin deposition studies DOI
Eskandar Moghimipour,

Mohammadamin Khazali,

Behzad Sharif Makhmalzadeh

et al.

Therapeutic Delivery, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 11

Published: Jan. 28, 2025

Aim The study aimed to formulate solid lipid nanoparticles (SLNs) for the transdermal delivery of PPL improve skin retention and efficacy.

Language: Английский

Citations

0